These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
216 related items for PubMed ID: 12793872
1. Bench-to-bedside review: severe lactic acidosis in HIV patients treated with nucleoside analogue reverse transcriptase inhibitors. Claessens YE, Chiche JD, Mira JP, Cariou A. Crit Care; 2003 Jun; 7(3):226-32. PubMed ID: 12793872 [Abstract] [Full Text] [Related]
2. Hyperlactataemia in HIV-infected patients: the role of NRTI-treatment. Vrouenraets SM, Treskes M, Regez RM, Troost N, Smulders YM, Weigel HM, Frissen PH, Brinkman K. Antivir Ther; 2002 Dec; 7(4):239-44. PubMed ID: 12553477 [Abstract] [Full Text] [Related]
9. Clinical features and risk factors of lactic acidosis following long-term antiretroviral therapy: 4 fatal cases. ter Hofstede HJ, de Marie S, Foudraine NA, Danner SA, Brinkman K. Int J STD AIDS; 2000 Sep 26; 11(9):611-6. PubMed ID: 10997508 [Abstract] [Full Text] [Related]
10. Lactic acidosis related to nucleoside therapy in HIV-infected patients. Falcó V, Crespo M, Ribera E. Expert Opin Pharmacother; 2003 Aug 26; 4(8):1321-9. PubMed ID: 12877640 [Abstract] [Full Text] [Related]
11. Hyperlactataemia syndromes associated with HIV therapy. Ogedegbe AE, Thomas DL, Diehl AM. Lancet Infect Dis; 2003 Jun 26; 3(6):329-37. PubMed ID: 12781504 [Abstract] [Full Text] [Related]
12. Riboflavin treatment of antiretroviral induced lactic acidosis and hepatic steatosis. Posteraro AF, Mauriello M, Winter SM. Conn Med; 2001 Jul 26; 65(7):387-90. PubMed ID: 11508132 [Abstract] [Full Text] [Related]
13. Detecting life-threatening lactic acidosis related to nucleoside-analog treatment of human immunodeficiency virus-infected patients, and treatment with L-carnitine. Claessens YE, Cariou A, Monchi M, Soufir L, Azoulay E, Rouges P, Goldgran-Toledano D, Branche F, Dhainaut JF. Crit Care Med; 2003 Apr 26; 31(4):1042-7. PubMed ID: 12682470 [Abstract] [Full Text] [Related]
14. Highly active antiretroviral therapy (HAART)-associated lactic acidosis: in vitro effects of combination of nucleoside analogues and protease inhibitors on mitochondrial function and lactic acid production. Nerurkar PV, Pearson L, Frank JE, Yanagihara R, Nerurkar VR. Cell Mol Biol (Noisy-le-grand); 2003 Dec 26; 49(8):1205-11. PubMed ID: 14983988 [Abstract] [Full Text] [Related]
16. Evidence for mitochondrial toxicity: lactic acidosis as proof of concept. Brinkman K. J HIV Ther; 2001 Mar 26; 6(1):13-6. PubMed ID: 11501196 [No Abstract] [Full Text] [Related]
17. Symptomatic hyperlactatemia associated with nucleoside analogue reverse-transcriptase inhibitor use in HIV-infected patients: a report of 24 cases in a resource-limited setting (Uganda). Songa PM, Castelnuovo B, Mugasha EB, Ocama P, Kambugu A. Clin Infect Dis; 2007 Aug 15; 45(4):514-7. PubMed ID: 17638205 [Abstract] [Full Text] [Related]
18. Hyperlactataemia and hepatic steatosis: mitochondrial toxicity of nucleoside reverse transcriptase inhibitors. Pao D, Watson C, Peters B, Lucas SB, Miller RF. Sex Transm Infect; 2001 Oct 15; 77(5):381-4. PubMed ID: 11588287 [No Abstract] [Full Text] [Related]
19. Lactic acidosis associated with nucleoside analog therapy in an HIV-positive patient. Goldfarb-Rumyantzev AS, Jeyakumar A, Gumpeni R, Rubin D. AIDS Patient Care STDS; 2000 Jul 15; 14(7):339-42. PubMed ID: 10935049 [Abstract] [Full Text] [Related]
20. Lactic acidosis secondary to nucleoside analogue antiretroviral therapy. Khouri S, Cushing H. AIDS Read; 2000 Oct 15; 10(10):602-6. PubMed ID: 11068807 [Abstract] [Full Text] [Related] Page: [Next] [New Search]